Skip to main content
logo
Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
31.37
-2.43 (-7.19%)
At close: Oct 30, 2026, 4:00 PM EST
29.49
-1.88 (-5.99%)
Pre-market: Nov 2, 2026, 4:19 AM EST

Nanobiotix Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
11.5132.59-7.1936.214.782.65
Revenue Growth
-64.70%--658.10%80.43%13.85%
Gross Profit
11.5132.59-7.1936.214.782.65
Operating Income
-29.62-10.88-68.26-24.24-45.72-47.17
Net Income
-52.87-23.96-68.13-39.7-57.04-47.06
Earnings Per Share
-1.09-0.50-1.44-1.08-1.64-1.35
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
110.8952.7549.7475.2841.3983.92
Total Debt
106.6195.3250.950.5753.1746.02
Net Cash (Debt)
4.28-42.57-1.1724.72-11.7837.9
Net Cash Growth
------45.99%
Net Cash Per Share
0.09-0.89-0.020.67-0.341.09

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-34.19-33.42-19.55-12.48-37.1-29.87
Capital Expenditures
-1.02-0.54-0.85-0.33-0.09-0.23
Free Cash Flow
-35.2-33.96-20.4-12.8-37.2-30.1
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%-100.00%100.00%100.00%
Operating Margin
-257.43%-33.39%--66.94%-957.22%-1781.83%
Pretax Margin
-459.35%-73.51%946.06%-109.32%-1194.12%-1775.52%
Profit Margin
-459.46%-73.52%--109.65%-1194.33%-1777.97%
FCF Margin
-305.94%-104.19%--35.36%-778.79%-1137.14%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
121.3728.95-19.938.6426.4296.13